{"disease":{"id":"severe-emphysema","name":"severe emphysema"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06332885","title":"Zephyr Valve Japan Post-Marketing Surveillance","phase":"","overall_status":"RECRUITING","enrollment_count":140,"lead_sponsor_name":"Pulmonx Corporation","has_results":false},{"nct_id":"NCT04559464","title":"Fissure Closure With the AeriSeal System for CONVERTing Collateral Ventilation Status (CONVERT)","phase":"NA","overall_status":"COMPLETED","enrollment_count":102,"lead_sponsor_name":"Pulmonx Corporation","has_results":false},{"nct_id":"NCT06152107","title":"A Multi-center RCT to Evaluate Subsegmental BTVA Treatment for Severe Emphysema","phase":"NA","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Shanghai Chest Hospital","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}